This in vitro study demonstrated that MOTS-c promotes homeostasis in aged human placenta-derived mesenchymal stem cells. MOTS-c treatment restored metabolic function and reduced aging markers in aged stem cells, suggesting the mitochondrial peptide could improve stem cell-based regenerative therapies by counteracting age-related stem cell decline.
Yu, Won Dong; Kim, Yu Jin; Cho, Min Jeong; Seok, Jin; Kim, Gi Jin; Lee, Chang-Han; Ko, Jung Jae; Kim, You Shin; Lee, Jae Ho